Low Molecular Weight Heparin in Advanced Non Small Cell Lung Cancer (NSCLC): a Randomized Open Label Phase III Study Evaluating the Effect of Enoxaparin (Clexane) on Survival and Symptom Control in Patients With Stage IIIB and IV NSCLC Undergoing a Cisplatin Based First Line Chemotherapy: the SYRINGES Trial
Phase of Trial: Phase III
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Enoxaparin sodium (Primary) ; Cisplatin; Docetaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms SYRINGES
- 10 Aug 2017 This trial has been discontinued in Belgium as reported by European Clinical Trials database.
- 17 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Oct 2008 New trial record.